Sebastian Wehle
Director/Board Member bei TIGENIX NV
Profil
Sebastian Wehle is currently working as an Executive Director at TiGenix NV since 2018.
Prior to this, he worked as the Head-Alofisel Manufacturing & Supply at Takeda Pharmaceutical Co., Ltd.
Dr. Wehle holds a doctorate degree from the University of Kiel.
Aktive Positionen von Sebastian Wehle
| Unternehmen | Position | Beginn |
|---|---|---|
| TIGENIX NV | Director/Board Member | 15.06.2018 |
Ehemalige bekannte Positionen von Sebastian Wehle
| Unternehmen | Position | Ende |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Ausbildung von Sebastian Wehle
| University of Kiel | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TiGenix NV
 TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
